Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug

BackgroundThe process of drug discovery and development is time-consuming and costly, and the probability of success is low. Therefore, there is rising interest in repositioning existing drugs for new medical indications. When successful, this process reduces the risk of failure and costs associated with de novo drug development. However, in many cases, new indications of existing drugs have been found serendipitously. Thus there is a clear need for establishment of rational methods for drug repositioning.ResultsIn this study, we have established a database we call “PharmDB” which integrates data associated with disease indications, drug development, and associated proteins, and known interactions extracted from various established databases. To explore linkages of known drugs to diseases of interest from within PharmDB, we designed the Shared Neighborhood Scoring (SNS) algorithm. And to facilitate exploration of tripartite (Drug-Protein-Disease) network, we developed a graphical data visualization software program called phExplorer, which allows us to browse PharmDB data in an interactive and dynamic manner. We validated this knowledge-based tool kit, by identifying a potential application of a hypertension drug, benzthiazide (TBZT), to induce lung cancer cell death.ConclusionsBy combining PharmDB, an integrated tripartite database, with Shared Neighborhood Scoring (SNS) algorithm, we developed a knowledge platform to rationally identify new indications for known FDA approved drugs, which can be customized to specific projects using manual curation. The data in PharmDB is open access and can be easily explored with phExplorer and accessed via BioMart web service (http://www.i-pharm.org/, http://biomart.i-pharm.org/).

[1]  Justin Lamb,et al.  The Connectivity Map: a new tool for biomedical research , 2007, Nature Reviews Cancer.

[2]  Adam J. Smith,et al.  The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..

[3]  Andrea Scozzafava,et al.  Carbonic anhydrase IX: A new druggable target for the design of antitumor agents , 2008, Medicinal research reviews.

[4]  E. Kunkel Systems biology in drug discovery , 2004, Nature Biotechnology.

[5]  Pankaj Agarwal,et al.  A Pathway-Based View of Human Diseases and Disease Relationships , 2009, PloS one.

[6]  C. Daub,et al.  BMC Systems Biology , 2007 .

[7]  Neil R. Smalheiser,et al.  Artificial Intelligence An interactive system for finding complementary literatures : a stimulus to scientific discovery , 1995 .

[8]  D. Goldberg,et al.  Assessing experimentally derived interactions in a small world , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Campbell Genetic association database , 2004, Nature Reviews Genetics.

[10]  Xue-jun Li,et al.  Acetazolamide suppresses tumor metastasis and related protein expression in mice bearing Lewis lung carcinoma. , 2002, Acta pharmacologica Sinica.

[11]  R Pastor-Satorras,et al.  Dynamical and correlation properties of the internet. , 2001, Physical review letters.

[12]  Martin Serrano,et al.  Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .

[13]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[14]  William Loging,et al.  High-throughput electronic biology: mining information for drug discovery , 2007, Nature Reviews Drug Discovery.

[15]  David S Wishart,et al.  Discovering drug targets through the web. , 2007, Comparative biochemistry and physiology. Part D, Genomics & proteomics.

[16]  Gabriele Ausiello,et al.  MINT: the Molecular INTeraction database , 2006, Nucleic Acids Res..

[17]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[18]  R. Khalifah,et al.  The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. , 1971, The Journal of biological chemistry.

[19]  Purvesh Khatri,et al.  Onto-Tools: an ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments , 2004, Nucleic Acids Res..

[20]  M. Newman,et al.  Mixing patterns in networks. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.

[21]  Albert-László Barabási,et al.  A Dynamic Network Approach for the Study of Human Phenotypes , 2009, PLoS Comput. Biol..

[22]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[23]  Ronald J. Quinn,et al.  Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. , 2009, Journal of the American Chemical Society.

[24]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[25]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[26]  Danli Wu,et al.  Hypoxic tumors and their effect on immune cells and cancer therapy. , 2010, Methods in molecular biology.

[27]  C W HAVARD,et al.  Clinical Evaluation of Benzthiazide, an Oral Diuretic , 1960, British medical journal.

[28]  Claudiu T. Supuran,et al.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.

[29]  Lu Huang,et al.  Update of TTD: Therapeutic Target Database , 2009, Nucleic Acids Res..

[30]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2011 , 2010, Nucleic Acids Res..

[31]  Russ B. Altman,et al.  Pharmacogenomics and bioinformatics: PharmGKB. , 2010, Pharmacogenomics.

[32]  T. Tatusova,et al.  Entrez Gene: gene-centered information at NCBI , 2006, Nucleic Acids Res..

[33]  Linyuan Lü,et al.  Similarity index based on local paths for link prediction of complex networks. , 2009, Physical review. E, Statistical, nonlinear, and soft matter physics.

[34]  Adrian L Harris,et al.  Role of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and Invasion , 2004, Cancer Research.

[35]  Guanghui Hu,et al.  Human Disease-Drug Network Based on Genomic Expression Profiles , 2009, PloS one.

[36]  Xiaoyan Zhu,et al.  Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts , 2009, PLoS Comput. Biol..

[37]  Christian Borgs,et al.  Finding undetected protein associations in cell signaling by belief propagation , 2010, Proceedings of the National Academy of Sciences.

[38]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..